Key facts
- This page summarizes George O'Leary's Form 4 filing for HealthLynked Corp (HLYK).
- 1 reported transaction and 2 derivative rows are listed below.
- Accepted by SEC: 06 Jun 2023, 16:05.
George O'Leary - 02 Jun 2023 Form 4 Insider Report for HealthLynked Corp (HLYK)
- Reporting relationship
- Chief Financial Officer, Director
- Issuer ticker
- HLYK
- Reported as of
- 02 Jun 2023
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 06 Jun 2023, 16:05:25 UTC
- Prior SEC filing
- 31 Jan 2023
- Next SEC filing
- 02 Jan 2025
- Source filing
- View source filing
- Reporting owner signature
- /s/ George O'Leary
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
George O'Leary filed Form 4 for HealthLynked Corp (HLYK) on 06 Jun 2023.
Change
- Previous filing in this sequence was filed on 31 Jan 2023.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
HLYK
transaction
Derivative
Warrants to purchase common stock
Other
- Transaction value
- $0
- Shares
- +261,194
- Change %
- Price
- $0.000000
- Shares after
- 261,194
- Date
- 02 Jun 2023
- Ownership
- Direct
- Underlying class
- Common stock
- Underlying amount
- 261,194
- Exercise price
- $0.0670
- Footnotes
- F1
HLYK
holding
Derivative
Options to purchase common stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 3,000,000
- Date
- 02 Jun 2023
- Ownership
- Direct
- Underlying class
- Common stock
- Underlying amount
- 3,000,000
- Exercise price
- Footnotes
- F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 2 footnotes
Footnote F1
Reporting person received the warrants to purchase shares of Issuer's common stock directly in connection with a loan agreement the reporting person entered into with the Issuer on the warrant date.
Footnote F2
Reflects previously issued derivative securities shown for beneficial ownership purposes only.